Parathyroid hormone (PTH) plays a central role in regulation of calcium metabolism but also has a role as an anabolic hormone for bone. The hormone appears to act through a single receptor on the osteoblast to elicit all of its skeletal effects, including its anabolic effects. We have shown that low concentrations of PTH (1012 and I 0"""""""" M) stimulate DNA synthesis and proliferation of osteoblastic cells in culture, and that this is due to selective activation of protein kinase C (PKC) resulting in activation of extra-cellular signal regulated kinases (ERKs). The most likely reason is because these concentrations of PTH interact with their receptor in such a way as to selectively activate certain Ga proteins (such as Gaq or Ga 2/13) leading to activation of PKC. The activation and role of this pathway has not been well documented in the osteoblast. Thus, the overall goal of the present competing renewal is to delineate how low concentrations of PTH signal through PKC and what the eventual targets of ERK activation are which lead to proliferation of osteoblastic cells. This will be done as a two-pronged approach: 1. determining how low concentrations of PTH signal though PKC in osteoblastic cells by: a) ascertaining the type of PKC isozyme activated by low concentrations of the hormone, b) assessing the signal transduction pathway activating the PKC isozyme(s), c) determining the G protein activating the particular phospholipase(s). 2. delineating the eventual targets of ERK activation which lead to proliferation of osteoblastic cells by: a) examining whether known ERK target genes are affected by treatment of osteoblastic cells with low concentrations of PTH, b) identifying other genes regulated by low concentrations of PTH, c) examining whether the changes in mRNA for the gene(s) are reflected in changes in protein levels, d) ablating the regulated gene(s) by either using dominant negative forms of the protein or inducible anti-sense RNA, and ascertaining if this prevents enhanced proliferation of osteoblastic cells by low doses of PTH. The results of this work will provide insight into one of the key pathways of regulation of the osteoblast. In so doing, the data may provide a foundation for development of small molecules that can be used in place of injected PTH for treatment of osteoporosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK048109-08
Application #
6400472
Study Section
General Medicine B Study Section (GMB)
Program Officer
Margolis, Ronald N
Project Start
1994-01-01
Project End
2005-06-30
Budget Start
2001-08-01
Budget End
2002-06-30
Support Year
8
Fiscal Year
2001
Total Cost
$284,702
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Physiology
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Tamasi, Joseph A; Vasilov, Anatoliy; Shimizu, Emi et al. (2013) Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone. J Bone Miner Res 28:1975-86
Raggatt, Liza J; Partridge, Nicola C (2010) Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285:25103-8
Boumah, Christine E; Lee, Minnkyong; Selvamurugan, Nagarajan et al. (2009) Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene. Mol Endocrinol 23:1255-63
Raggatt, Liza J; Qin, Ling; Tamasi, Joseph et al. (2008) Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. J Biol Chem 283:6790-8
Li, Xin; Qin, Ling; Bergenstock, Marika et al. (2007) Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem 282:33098-106
Li, Xin; Liu, Hao; Qin, Ling et al. (2007) Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem 282:33086-97
Selvamurugan, Nagarajan; Jefcoat, Stephen C; Kwok, Sukyee et al. (2006) Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J Cell Biochem 99:545-57
Kwok, Sukyee; Qin, Ling; Partridge, Nicola C et al. (2005) Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells. J Cell Biochem 95:1002-11
Qin, Ling; Tamasi, Joseph; Raggatt, Liza et al. (2005) Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280:3974-81
Qin, Ling; Partridge, Nicola C (2005) Stimulation of amphiregulin expression in osteoblastic cells by parathyroid hormone requires the protein kinase A and cAMP response element-binding protein signaling pathway. J Cell Biochem 96:632-40

Showing the most recent 10 out of 22 publications